Los Angeles CA USA
Welcome to Regulatory Reconnaissance, your daily regulatory news and intelligence briefing. Read anything we might be interested in sharing? Let us know: email@example.com.
The US Food and Drug Administration (FDA) has published a new draft guidance intended to assist industry with developing products under the agency's so-called "Animal Rule," a regulatory pathway intended to facilitate approvals of medical countermeasures to rare, emerging or serious pathogens.
The US Food and Drug Administration (FDA) is looking for a new director for its Office of Criminal Investigations (OCI), it announced on Thursday.